Citations 2
DURABLES RESPONSES WITH ANTI‐CD19 ALLOGENEIC CAR T ALLO‐501/501A IN PHASE 1 TRIALS OF RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA (R/R LBCL)
Lekakis, Lazaros J. , Eradat, Herbert, Tees, Michael, Vos, Sven de , Nath, R., Stevens, Don A., Popplewell, Leslie , Goyal, Lovely, Navale, Lynn, Kaufman, G., Kai, Kazuharu, Balakumaran, Arun, Neelapu, Sattva S. , Locke, Frederick L. , Muñoz, Javier , Malik, S., Hamadani, Mehdi , Oluwole, Olalekan O. , Perales, Miguel‐Angel , Miklos, David B. , Fisher, Paul Graham
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 85-86
LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN R/R CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)/SMALL LYMPHOCYTIC LYMPHOMA (SLL): PRIMARY ANALYSIS OF TRANSCEND CLL 004
Maloney, David G. , Brander, Danielle M. , Dorritie, Kathleen , Shah, Nirav N. , Nath, R., Feldman, Tatyana , Solomon, Scott R. , Perna, Serena , Tuazon, Sherilyn A. , Ou, San San, Wierda, William G. , Siddiqi, Tanya , Kenderian, Saad S. , Soumerai, Jacob D. , Riedell, Peter A. , Fakhri, Bita , Stephens, Deborah M. , Ma, Shuo , Schuster, Stephen J. , Ou, San‐San , Papp, Eniko , Chen, Yuling , Wierda, William G.
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 60-62